ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China.

Almirall is a leading global pharmaceutical company, focused in medical dermatology and headquartered in Barcelona. Our strong commitment is to improve patients’ quality life while caring and listening to them. We work to offer innovative and differentiated medicines for skin conditions with high unmet need. We cover the whole of the drug value chain through an expert R&D organisation as well as key partnerships.

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Beau de Loménie is a Pan European IP firm with a worldwide standing. For more than 50 years, the firm has been developing a solid network of branches intended to offer its clients a dedicated, high-quality and local service, while still benefiting from the resources of a large organisation.

Capital Grand Est is an asset management company based in Strasbourg – France.
The company manages over €180M.
Capital Grand Est is mainly focused on investing in growing SMEs and promising young Start-Ups located in the eastern part of France.

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,900 employees provide the highest quality stand-alone and integrated drug discovery and development solutions from target to clinic. For additional information, please go to www.evotec.com and follow us on Twitter @Evotec.

The INPI acts in favour of economic development through its actions to promote innovation: registration and issue of industrial property titles (patents, trademarks, designs and models, Soleau envelopes); receipt and examination of applications for geographical indications.

Johnson & Johnson Innovation seeks to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve people’s lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.

Our mission is to create the leading global innovation network to generate transformational healthcare solutions through value-creating partnerships.

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”

More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.

Pfizer CentreOne® is a global CDMO within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply.

Working together with our customers, we combine our knowledge with open dialogue to solve challenges. For more information, visit www.pfizercentreone.com.

Assists small biotechs and larger biopharmaceutical companies at each step of the drug development process

Roche is a leading healthcare company and is heavily investing into R&D, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the CNS. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech’s R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy.

Roquette is a family-owned global leader in plant-based ingredients,  and a leading provider of pharmaceutical excipients.

Founded in 1933, the company currently operates in more than 100 countries, has a turnover of 5 billion euros, and employs more than 10,000 people worldwide.

Life and nature have been our sources of inspiration for decades. All our raw materials are of natural origin. From them we develop a diverse portfolio of versatile and reliable excipients for the pharmaceutical, nutraceutical and biopharmaceutical markets.

Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience and animal health expertise, using behavioral, electrophysiological and protein-based biomarker assays to help clients benchmark compounds. Committed to on-time data delivery and flexible, customized solutions we support clients in optimizing preclinical assets for the development of life-changing medicines.

VIB is a life sciences research institute, based in Flanders, Belgium. Some 1,500 top VIB scientists conduct pioneering basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial applications. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This leads to additional employment and bridges the gap between scientific research and entrepreneurship.